Literature DB >> 25006726

Spironolactone for heart failure with preserved ejection fraction.

Marc A Pfeffer, Bertram Pitt, Sonja M McKinlay.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25006726     DOI： 10.1056/NEJMc1405715

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Utility of the Cardiovascular Physical Examination and Impact of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Senthil Selvaraj; Brian Claggett; Sanjiv J Shah; Inder S Anand; Jean L Rouleau; Akshay S Desai; Eldrin F Lewis; Muthiah Vaduganathan; Stephen Y Wang; Bertram Pitt; Nancy K Sweitzer; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2019-06-21       Impact factor: 8.790

2.  Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Senthil Selvaraj; Brian Claggett; Sanjiv J Shah; Inder Anand; Jean L Rouleau; Eileen O'Meara; Akshay S Desai; Eldrin F Lewis; Bertram Pitt; Nancy K Sweitzer; James C Fang; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2018-11       Impact factor: 8.790

3.  Nitric oxide-sensitive guanylyl cyclase stimulation improves experimental heart failure with preserved ejection fraction.

Authors:  Nicola Wilck; Lajos Markó; András Balogh; Kristin Kräker; Florian Herse; Hendrik Bartolomaeus; István A Szijártó; Maik Gollasch; Nadine Reichhart; Olaf Strauss; Arnd Heuser; Damian Brockschnieder; Axel Kretschmer; Ralf Lesche; Florian Sohler; Johannes-Peter Stasch; Peter Sandner; Friedrich C Luft; Dominik N Müller; Ralf Dechend; Nadine Haase
Journal:  JCI Insight       Date:  2018-02-22

Review 4.  Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target.

Authors:  Katharina Schimmel; Kenzo Ichimura; Sushma Reddy; Francois Haddad; Edda Spiekerkoetter
Journal:  Front Cardiovasc Med       Date:  2022-05-06

Review 5.  Spironolactone for Management of Heart Failure with Preserved Ejection Fraction: Whither to After TOPCAT?

Authors:  Sumeet S Mitter; Sanjiv J Shah
Journal:  Curr Atheroscler Rep       Date:  2015-11       Impact factor: 5.113

6.  Pharmacological interventions for heart failure in people with chronic kidney disease.

Authors:  Meaghan Lunney; Marinella Ruospo; Patrizia Natale; Robert R Quinn; Paul E Ronksley; Ioannis Konstantinidis; Suetonia C Palmer; Marcello Tonelli; Giovanni Fm Strippoli; Pietro Ravani
Journal:  Cochrane Database Syst Rev       Date:  2020-02-27

7.  A Feline HFpEF Model with Pulmonary Hypertension and Compromised Pulmonary Function.

Authors:  Markus Wallner; Deborah M Eaton; Remus M Berretta; Giulia Borghetti; Jichuan Wu; Sandy T Baker; Eric A Feldsott; Thomas E Sharp; Sadia Mohsin; Mark A Oyama; Dirk von Lewinski; Heiner Post; Marla R Wolfson; Steven R Houser
Journal:  Sci Rep       Date:  2017-11-29       Impact factor: 4.379

8.  Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction.

Authors:  Adam K McDiarmid; Peter P Swoboda; Bara Erhayiem; Katrina A Bounford; Petra Bijsterveld; Keith Tyndall; Graham J Fent; Pankaj Garg; Laura E Dobson; Tarique A Musa; James R J Foley; Klaus K Witte; Mark T Kearney; John P Greenwood; Sven Plein
Journal:  J Am Heart Assoc       Date:  2019-12-19       Impact factor: 5.501

9.  Circulating S-Glutathionylated cMyBP-C as a Biomarker for Cardiac Diastolic Dysfunction.

Authors:  Xiaoxu Zhou; Euy-Myoung Jeong; Hong Liu; Bahaa Kaseer; Man Liu; Suvash Shrestha; Hafiz Imran; Kylie Kavanagh; Ning Jiang; Lori-Ann Desimone; Feng Feng; Guangbin Shi; Go Eun Jeong; Anyu Zhou; Philip Stockwell; Samuel C Dudley
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

10.  Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.

Authors:  Edmund Ym Chung; Marinella Ruospo; Patrizia Natale; Davide Bolignano; Sankar D Navaneethan; Suetonia C Palmer; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2020-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.